Pieris appoints chief scientific officer
Joins German firm from Merck & Co bringing therapeutic protein drug development expertise
‘Laurent’s pharmacology expertise and drug development skills are the precise ingredients we need to maximise the value of our growing therapeutic pipeline,’ saidd Stephen Yoder, chief executive of Pieris.
‘As the company builds and expands its internal and partnered Anticalin pipeline, Laurent's contribution will be significant.’